Credit Rating
Gufic Biosciences Ltd has informed BSE regarding "Credit Rating".19-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Gufic Biosciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-07-2016
Shareholding for the Period Ended June 30, 2016
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here18-07-2016
Corrigendum in the Outcome of Board Meeting
Gufic Biosciences Ltd has informed BSE regarding Corrigendum in the Outcome of the Board Meeting held on May 30, 2016.08-06-2016
Board recommends Dividend
Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016 at 4.30 p.m. and concluded at 8:45 p.m., inter alia, has transacted the following :1. Recommended payment of dividend of Rs. 0.05 (i.e. 5%) per equity share for the year ended March 31, 2016.2. Approved Appointment of Ms. Ami Naresh Shah as Company Secretary of the Company w.e.f. March 22, 2016 and re-designated as...31-05-2016
Standalone Financial Results, Auditors Report for March 31, 2016
Gufic Biosciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Auditors Report for the period ended March 31, 201631-05-2016
Board to consider Dividend
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2016 and recommend dividend for the financial year 2015-16, if any.Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015...20-05-2016
Shareholding for the Period Ended March 31, 2016
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here21-04-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Gufic Biosciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.20-04-2016